Donald W. Everett

904 total citations
12 papers, 753 citations indexed

About

Donald W. Everett is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Donald W. Everett has authored 12 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Donald W. Everett's work include Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Donald W. Everett is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). Donald W. Everett collaborates with scholars based in United States, Germany and Netherlands. Donald W. Everett's co-authors include Theodore J. Chando, Donglu Zhang, W. Griffith Humphreys, Shangara S. Dehal, Christopher Patten, Steven M. Paul, David Pickar, Markku Linnoila, Daniel W. Hommer and Rodrigo Labarca and has published in prestigious journals such as Science, Antimicrobial Agents and Chemotherapy and Drug Metabolism and Disposition.

In The Last Decade

Donald W. Everett

12 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald W. Everett United States 11 177 162 157 130 122 12 753
Peter Dogterom Netherlands 18 153 0.9× 206 1.3× 83 0.5× 51 0.4× 76 0.6× 41 896
Manoranjenni Chetty United Kingdom 18 217 1.2× 221 1.4× 141 0.9× 72 0.6× 205 1.7× 41 953
David J. Freeman Canada 20 161 0.9× 318 2.0× 107 0.7× 32 0.2× 182 1.5× 41 1.2k
Heidi L. Liston United States 10 202 1.1× 100 0.6× 258 1.6× 25 0.2× 183 1.5× 12 712
Alex Hemeryck Belgium 12 204 1.2× 220 1.4× 112 0.7× 37 0.3× 134 1.1× 15 784
Lisa Von Moltke United States 16 115 0.6× 167 1.0× 225 1.4× 90 0.7× 111 0.9× 47 674
Miriam Saiz‐Rodríguez Spain 19 351 2.0× 191 1.2× 166 1.1× 53 0.4× 183 1.5× 58 984
S Vandel France 15 217 1.2× 71 0.4× 295 1.9× 64 0.5× 57 0.5× 74 783
Ryan Z. Turncliff United States 18 217 1.2× 161 1.0× 191 1.2× 34 0.3× 361 3.0× 24 1.1k
Pablo Zubiaur Spain 17 332 1.9× 161 1.0× 171 1.1× 38 0.3× 130 1.1× 73 877

Countries citing papers authored by Donald W. Everett

Since Specialization
Citations

This map shows the geographic impact of Donald W. Everett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald W. Everett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald W. Everett more than expected).

Fields of papers citing papers by Donald W. Everett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald W. Everett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald W. Everett. The network helps show where Donald W. Everett may publish in the future.

Co-authorship network of co-authors of Donald W. Everett

This figure shows the co-authorship network connecting the top 25 collaborators of Donald W. Everett. A scholar is included among the top collaborators of Donald W. Everett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald W. Everett. Donald W. Everett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Zhang, Donglu, W. Griffith Humphreys, Samuel J. Bonacorsi, et al.. (2009). Biotransformation Profiling of [14C]Ixabepilone in Human Plasma, Urine and Feces Samples Using Accelerator Mass Spectrometry (AMS). Drug Metabolism and Pharmacokinetics. 24(6). 511–522. 16 indexed citations
3.
Li, Wenying, Donglu Zhang, Lifei Wang, et al.. (2006). BIOTRANSFORMATION OF CARBON-14-LABELED MURAGLITAZAR IN MALE MICE: INTERSPECIES DIFFERENCE IN METABOLIC PATHWAYS LEADING TO UNIQUE METABOLITES. Drug Metabolism and Disposition. 34(5). 807–820. 10 indexed citations
4.
Zhang, Donglu, Theodore J. Chando, Donald W. Everett, et al.. (2005). IN VITRO INHIBITION OF UDP GLUCURONOSYLTRANSFERASES BY ATAZANAVIR AND OTHER HIV PROTEASE INHIBITORS AND THE RELATIONSHIP OF THIS PROPERTY TO IN VIVO BILIRUBIN GLUCURONIDATION. Drug Metabolism and Disposition. 33(11). 1729–1739. 223 indexed citations
5.
Wang, Lifei, Donglu Zhang, Arun Swaminathan, et al.. (2005). GLUCURONIDATION AS A MAJOR METABOLIC CLEARANCE PATHWAY OF 14C-LABELED MURAGLITAZAR IN HUMANS: METABOLIC PROFILES IN SUBJECTS WITH OR WITHOUT BILE COLLECTION. Drug Metabolism and Disposition. 34(3). 427–439. 25 indexed citations
6.
Everett, Donald W., Thomas Franz, Theodore J. Chando, et al.. (1999). Percutaneous absorption of [3H]tretinoin and systemic exposure to mequinol after dermal application of 2% mequinol/0.01% [3H]tretinoin (Solagé®) solution in healthy volunteers. Biopharmaceutics & Drug Disposition. 20(6). 301–308. 1 indexed citations
7.
Vachharajani, Nimish N., Wen Chyi Shyu, Theodore J. Chando, et al.. (1998). Oral Bioavailability and Disposition Characteristics of Irbesartan, an Angiotensin Antagonist, in Healthy Volunteers. The Journal of Clinical Pharmacology. 38(8). 702–707. 42 indexed citations
8.
Chando, Theodore J., Donald W. Everett, Nimish N. Vachharajani, et al.. (1998). Biotransformation of irbesartan in man.. PubMed. 26(5). 408–17. 60 indexed citations
9.
Everett, Donald W., et al.. (1991). Biotransformation of pravastatin sodium in humans.. Drug Metabolism and Disposition. 19(4). 740–748. 100 indexed citations
10.
Kripalani, K. J., S. M. Singhvi, Stephen H. Weinstein, et al.. (1984). Disposition of [14C]aztreonam in rats, dogs, and monkeys. Antimicrobial Agents and Chemotherapy. 26(2). 119–126. 10 indexed citations
11.
Pickar, David, Rodrigo Labarca, Markku Linnoila, et al.. (1984). Neuroleptic-Induced Decrease in Plasma Homovanillic Acid and Antipsychotic Activity in Schizophrenic Patients. Science. 225(4665). 954–957. 218 indexed citations
12.
Everett, Donald W., et al.. (1980). Metabolism ofo-[methyl-14C]toluidine in the F344 rat. Xenobiotica. 10(7-8). 457–468. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Dogterom Breakdown of academic impact, for papers by Manoranjenni Chetty Breakdown of academic impact, for papers by David J. Freeman Breakdown of academic impact, for papers by Heidi L. Liston Breakdown of academic impact, for papers by Alex Hemeryck Breakdown of academic impact, for papers by Lisa Von Moltke Breakdown of academic impact, for papers by Miriam Saiz‐Rodríguez Breakdown of academic impact, for papers by S Vandel Breakdown of academic impact, for papers by Ryan Z. Turncliff Breakdown of academic impact, for papers by Pablo Zubiaur
Rankless by CCL
2026